244 related articles for article (PubMed ID: 18567838)
21. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.
Wall J; Schell M; Murphy C; Hrncic R; Stevens FJ; Solomon A
Biochemistry; 1999 Oct; 38(42):14101-8. PubMed ID: 10529258
[TBL] [Abstract][Full Text] [Related]
22. Novel isolated cerebral ALlambda amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy.
Schröder R; Deckert M; Linke RP
J Neuropathol Exp Neurol; 2009 Mar; 68(3):286-99. PubMed ID: 19225408
[TBL] [Abstract][Full Text] [Related]
23. Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation.
Wolwertz ML; Nguyen PT; Quittot N; Bourgault S
Biochim Biophys Acta; 2016 Apr; 1864(4):409-18. PubMed ID: 26802902
[TBL] [Abstract][Full Text] [Related]
24. Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.
Granzow M; Hegenbart U; Hinderhofer K; Hose D; Seckinger A; Bochtler T; Hemminki K; Goldschmidt H; Schönland SO; Jauch A
Haematologica; 2017 Jul; 102(7):1281-1290. PubMed ID: 28341732
[TBL] [Abstract][Full Text] [Related]
25. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
Miura K; Shirasawa H
Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
[TBL] [Abstract][Full Text] [Related]
26. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a functional human Ig V lambda VI germline gene.
Ch'ang LY; Yen CP; Besl L; Schell M; Solomon A
Mol Immunol; 1994 May; 31(7):531-6. PubMed ID: 8190128
[TBL] [Abstract][Full Text] [Related]
28. Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.
Enqvist S; Sletten K; Stevens FJ; Hellman U; Westermark P
PLoS One; 2007 Oct; 2(10):e981. PubMed ID: 17912358
[TBL] [Abstract][Full Text] [Related]
29. Formation of amyloid fibers by monomeric light chain variable domains.
Brumshtein B; Esswein SR; Landau M; Ryan CM; Whitelegge JP; Phillips ML; Cascio D; Sawaya MR; Eisenberg DS
J Biol Chem; 2014 Oct; 289(40):27513-25. PubMed ID: 25138218
[TBL] [Abstract][Full Text] [Related]
30. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis
Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W
Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
[TBL] [Abstract][Full Text] [Related]
31. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
[TBL] [Abstract][Full Text] [Related]
32. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
Pelaez-Aguilar AE; Rivillas-Acevedo L; French-Pacheco L; Valdes-Garcia G; Maya-Martinez R; Pastor N; Amero C
Biochemistry; 2015 Aug; 54(32):4978-86. PubMed ID: 26214579
[TBL] [Abstract][Full Text] [Related]
34. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
[TBL] [Abstract][Full Text] [Related]
35. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis.
Zaky ZS; Liepnieks JJ; Rex DK; Cummings OW; Benson MD
Amyloid; 2007 Dec; 14(4):299-304. PubMed ID: 17968691
[TBL] [Abstract][Full Text] [Related]
36. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
Hernández-Santoyo A; del Pozo Yauner L; Fuentes-Silva D; Ortiz E; Rudiño-Piñera E; Sánchez-López R; Horjales E; Becerril B; Rodríguez-Romero A
J Mol Biol; 2010 Feb; 396(2):280-92. PubMed ID: 19941869
[TBL] [Abstract][Full Text] [Related]
37. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
38. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
[TBL] [Abstract][Full Text] [Related]
39. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
[TBL] [Abstract][Full Text] [Related]
40. Splenic plasma cells can serve as a source of amyloidogenic light chains.
Solomon A; Macy SD; Wooliver C; Weiss DT; Westermark P
Blood; 2009 Feb; 113(7):1501-3. PubMed ID: 19050307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]